| Bioactivity | Edecesertib (GS-5718) is a selective, potent, orally active IRAK-4 inhibitor. Edecesertib has anti-inflammatory activity. Edecesertib can be used for rheumatoid arthritis (RA) and lupus erythematosus (LE) research[1][2]. |
| Name | Edecesertib |
| CAS | 2408839-73-4 |
| Formula | C22H22FN7O2 |
| Molar Mass | 435.45 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Roedder S, et, al. Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects. 2021 Nov 6. [2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical |
Edecesertib
CAS: 2408839-73-4 F: C22H22FN7O2 W: 435.45
Edecesertib (GS-5718) is a selective, potent, orally active IRAK-4 inhibitor. Edecesertib has anti-inflammatory activity
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.